H

HOOKIPA Pharma Inc.

123 employees

Hookipa is a clinical stage biotech company developing best-in-class active immunization therapies for infectious diseases and oncology.

Basic info

Industry

biotechnology research

Sectors

Clinical Trials
Biotechnology
Infectious diseases
Therapeutics
Immunotherapy
Immuno-Oncology

Date founded

2011

Funding rounds raised

Total raised

$60M

from 23 investors over 23 rounds

H

HOOKIPA Pharma Inc. raised $37M on February 26, 2019

Investors: Takeda UK Limited, Redmile Group, The Invus Group and Samsara BioCapital

H

HOOKIPA Pharma Inc. raised $60M on December 11, 2017

Investors: The Gilead Group, LLC, HBM Partners AG, Hillhouse Capital Management, Forbion, Sirona Capital, BioMedPartners, Takeda UK Limited and Sofinnova Partners

H

HOOKIPA Pharma Inc. raised $11M on December 1, 2016

Investors: Sofinnova Partners, Forbion, BioMedPartners and Takeda UK Limited

H

HOOKIPA Pharma Inc. raised $4.6M on October 17, 2016

Investors: FFG Österreichische Forschungsförderungsgesellschaft mbH

H

HOOKIPA Pharma Inc. raised $27M on November 4, 2013

Investors: Forbion, Sofinnova Partners, Takeda UK Limited and BioMedPartners

H

HOOKIPA Pharma Inc. raised $9.6M on October 18, 2011

Investors: Forbion and Sofinnova Partners

FAQ